• Mashup Score: 5

    Doing What’s Best for Your Patients: Putting the Latest Findings from the 2022 ASCO Annual Meeting Into Practice in LMIC Settings To guide physicians in low- and middle-income countries (LMICs) in putting the latest science and evidence from the 2022 ASCO Annual Meeting into practice, ASCO is offering two free webinars in the weeks following the meeting. Each webinar will be 30 minutes long, with…

    Tweet Tweets with this article
    • Join us for a free webinar on June 29 to guide physicians in #LMICs in putting the latest #ASCO22 #GIcancer science & evidence into practice. 📅 Register: https://t.co/aWDQkPmuRZ #gicsm #GI22 @JCOGO_ASCO #GlobalOncology #globonc

  • Mashup Score: 2

    Durvalumab Combination for Biliary Tract CancerThis trial randomly assigned patients with previously untreated locally advanced or metastatic biliary tract cancer to receive durvalumab or placebo i…

    Tweet Tweets with this article
    • Well, this publication is extremely timely— results from TOPAZ-1, presented initially at #GI22, now in @NEJM for #ASCO22 Day 1. Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer | NEJM Evidence https://t.co/RBdgRwrwZL